All News
A behind-the-scenes look at the 2025 Breakthrough West agenda — see you in SF?
A note from our editorial director of events on STAT Breakthrough Summit West. Only 3 weeks left — join us live in San Francisco on May 14.
Read MoreEarly Risks for Alzheimer's; Parkinson's Stem Cell Trials; Digital Dementia Debunked
(MedPage Today) -- In the U.S., key risk factors for Alzheimer's disease were tied to cognitive function as early as ages 24 to 44.
Read MoreFDA suspends milk quality-control testing program after Trump layoffs
Effective Monday, the agency suspends its proficiency testing program for grade ‘A’ raw milk and finished productsThe Food and Drug Administration is suspending a quality-control program for testi
Read MoreIsturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes?
(MedPage Today) -- The FDA expanded the approval of osilodrostat (Isturisa) to include treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or
Read MoreFact-Checking RFK Jr.'s Claims About Measles, Autism, and Diet
(MedPage Today) -- In just 2 months as the federal health secretary, Robert F. Kennedy Jr. has made sweeping changes to HHS -- and its priorities.
Read MoreAdvanced cancers returned to pre-pandemic levels, according to a reassuring report
Many were forced to postpone cancer screenings for several months in 2020 as Covid-19 overwhelmed doctors and hospitals, but that delay in screening isn't making a huge impact on cancer statistics.
Read MoreWhat Trump’s AI memos mean for health care
In this edition of STAT's Health Tech newsletter: What Trump's AI memos mean for health care, and more health tech news.
Read MoreCould Trump's War on Harvard Spell the End of U.S. Leadership in Science?
(MedPage Today) -- I was on the frontlines when COVID-19 hit and it felt like a surprise attack.
Read MoreRotavirus Vaccines Involve Several Special Considerations
(MedPage Today) -- The rotavirus vaccine is the only live oral vaccine on the CDC's recommended schedule of childhood immunizations.
Read MoreSTAT+: An ‘insane’ calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates
A pharma company raised the price for a rare disease drug by 150%, arguing a new U.S. law left it no other choice.
Read More